First-in-class HPLC-fluorescence method for quantification of roscovitine in plasma: Greenness assessment and application to pharmacokinetic studies in rats
By: Ibrahim A. Darwish and Nourah Z. Alzoman
References
- H. K. Alhashimi, M. A. A. Najm and H. N. K. AL-Salman, Targeting cyclin-dependent kinases (CDKs) for cancer therapy: An in-depth review of molecular candidates, their synthesis, evaluation, and future directions, Farm. Polska 81 (2025) 489–499; https://doi.org/10.32383/farmpol/218224
- N. Raje, S. Kumar, T. Hideshima, A. Roccaro, K. Ishitsuka, H. Yasui, N. Shiraishi, D. Chauhan, N. C. Munshi, S. R. Green and K. C. Anderson, Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma, Blood 106 (2005) 1042–1047; https://doi.org/10.1182/blood-2005-01-0320
- K. Bettayeb, D. Baunbæk, C. Delehouze, N. Loaëc, A. J. Hole, S. Baumli, J. A. Endicott, S. Douc-Rasy, J. Bénard, N. Oumata, H. Galons and L. Meijer, CDK inhibitors roscovitine and CR8 trigger Mcl-1 down-regulation and apoptotic cell death in neuroblastoma cells, Genes Cancer 1 (2010) 369–380; https://doi.org/10.1177/1947601910369817
- J. Cicenas, K. Kalyan, A. Sorokinas, E. Stankunas, J. Levy, I. Meskinyte, V. Stankevicius, A. Kaupinis and M. Valius, Roscovitine in cancer and other diseases, Ann. Transl. Med. 3(10) (2015) Article ID 135 (12 pages); https://doi.org/10.3978/j.issn.2305-5839.2015.03.61
- M. S. Alsalhi, M. Al-Outaibi and I. A. Darwish, Development of three innovative green microwell spectrometric methods with high throughput for determination of seleciclib in its bulk form and capsules, Sust. Chem. Pharm. 37 (2024) Article ID 101443; https://doi.org/10.1016/j.scp.2024.101443
- I. A. Darwish and N. Z. Alzoman, Development of green and high throughput microplate reader--assisted universal microwell spectrophotometric assay for direct determination of tyrosine kinase inhibitors in their pharmaceutical formulations irrespective the diversity of their chemical structures, Molecules 28 (2023) Article ID 4049 (19 pages); https://doi.org/10.3390/molecules28104049
- G. Xie, M. Liao, B. Wang and C. Zhang, Determination of seliciclib enantiomeric purity by HPLC on chiral stationary phase, Chromatographia 79 (2016) 641–646; https://doi.org/10.1007/s10337-016-3067-3
- P. Orság, L. H. I. Fojt, J. Coufal, V. Brázda and M. Fojta, Voltammetric behavior of a candidate anti-cancer drug seliciclib at carbon electrodes in aqueous buffers and a cell culture medium, Monatsh. Chem. 150 (2019) 461–467; https://doi.org/10.1007/s00706-018-2333-5
- M. Vita, L. Meurling, T. Pettersson, M. Cruz-Sidén, Å. Sidén and M. Hassan, Analysis of roscovitine using novel high performance liquid chromatography and UV-detection method: Pharmacokinetics of roscovitine in rat, J. Pharm. Biomed. Anal. 34(2) (2004) 425–431; https://doi.org/10.1016/S0731-7085(03)00534-X
- M. Vita, M. Abdel-Rehim, S. Olofsson, Z. Hassan, L. Meurling, A. Sidén, M. Sidén, T. Pettersson and M. Hassan, Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat, Pharm. Sci. 25(1) (2005) 91–103; https://doi.org/10.1016/j.ejps.2005.02.001
- M. Vita, P. Skansen, M. Hassan and M. Abdel-Rehim, Development and validation of a liquid chromatography and tandem mass spectrometry method for determination of roscovitine in plasma and urine samples utilizing on-line sample preparation, J. Chromatogr. B 817 (2005) 303–307; https://doi.org/10.1016/j.jchromb.2004.12.018
- M. Karady, O. Novák, A. Horna, M. Strnad and K. Doležal, High performance liquid chromatography-electrochemistry-electrospray ionization mass spectrometry (HPLC/EC/ESI-MS) for detection and characterization of roscovitine oxidation products, Electroanalysis 23 (2011) 2898–2905; https://doi.org/10.1002/elan.201100383
- A. Y. Sayed, N. Y. Khalil, A. Almomen, A. A. Almehizia and I. A. Darwish, A highly sensitive nonextraction-assisted HPLC method with fluorescence detection for quantification of duvelisib in plasma samples and its application to pharmacokinetic study in rats, Drug Des. Dev. Ther. 15 (2021) 2667–2677; https://doi.org/10.2147/dddt.s318714
- ICH, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH Harmonised Guideline, Bioanalytical Method Validation and Study Sample Analysis: M10, ICH, Geneva 2022.
- A. Gałuszka, P. Konieczka, Z. M. Migaszewski and J. Namieśnik, Analytical eco-scale for assessing the greenness of analytical procedures, Trends Anal. Chem. 37 (2012) 61–72; https://doi.org/10.1016/j.trac.2012.03.013
- J. Płotka-Wasylka, A new tool for the evaluation of the analytical procedure: Green analytical procedure index, Talanta 181 (2018) 204–209; https://doi.org/10.1016/j.talanta.2018.01.013
- F. Pena-Pereira, W. Wojnowski and M. Tobiszewski, AGREE-analytical greenness metric approach and software, Anal. Chem. 92 (2020) 10076–10082; https://doi.org/10.1021/acs.analchem.0c01887
- N. Manousi, W. Wojnowski, J. Płotka-Wasylka and V. Samanidou, Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality, Green Chem. 25 (2023) 7598–7604; https://doi.org/10.1039/D3GC02347H
- J. Płotka-Wasylka and J. Namieśnik (Eds.), Green Analytical Chemistry: Past, Present and Perspectives, Springer Nature Singapore Pte Ltd., Singapore 2019; https://doi.org/10.1007/978-981-13-9105-7
- I. A. Darwish, N. Z. Alzoman and M. S. Alsalhi, A green and highly sensitive microwell spectrofluorimetric method with high throughput for the determination of pemigatinib based on dual fluorescence enhancement by photoinduced electron transfer blocking and micellization: Application to the analysis of tablets, content uniformity testing, and human plasma, Luminescence 39(6) (2024) e4813; https://doi.org/10.1002/bio.4813
- L. Meijer, G. Hery-Arnaud, C. Leven, E. Nowak, S. Hillion, Y. Renaudineau, I. Durieu, R. Chiron, A. Prevotat, I. Fajac, D. Hubert, M. Murris-Espin, S. Huge, I. Danner-Boucher, B. Ravoninjatovo, S. Leroy, J. Macey, T. Urban, G. Rault, D. Mottier and R. Le Berre, Safety and pharmacokinetics of roscovitine (seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study, J. Cyst. Fibrosis 21 (2022) 529–536; https://doi.org/10.1016/j.jcf.2021.10.013
- E. M. Blais, K. D. Rawls, B. V. Dougherty, Z. I. Li, G. L. Kolling, P. Ye, A. Wallqvist and J. A. Papin, Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions, Nat. Commun. 8 (2017) Article ID 14250 (15 pages); https://doi.org/10.1038/ncomms14250
Language: English
Published on: Oct 13, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Ibrahim A. Darwish, Nourah Z. Alzoman, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.